This increased Drp1 association with the mitochondria was significantly reduced by treating the AD patient-derived fibroblasts with 1 μM P110 (1 μM every 24 hours for 3 days; Figure 3B). The gene discussed is DNM1L; the disease is Alzheimer disease.